We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01373151
Recruitment Status : Completed
First Posted : June 14, 2011
Last Update Posted : September 19, 2017
Information provided by (Responsible Party):
Vitaeris INC

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : September 2012
  Study Completion Date : June 2015
  Certification or Request for Extension to Delay Results Submission: July 24, 2015